Flynn Pharma
Pfizer successfully appeals 2,600% price hiking case
June 8, 2018Medical Communications Flynn Pharma, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer and co-defendant Flynn Pharma have won their appeal against a £90 million fine imposed on them by the Competition …
Pfizer slapped with record £84.2 million fine for 2,600% price increase
December 7, 2016Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine
Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
Pfizer fined for epilepsy drug price increase by UK antitrust regulator
April 15, 2016Medical Communications CMA, Flynn Pharma, Pfizer, antitrust, competition and markets authority, epilepsy, fine, flynn
Pfizer has been fined for unfairly increasing the price of epilepsy drug Epanutin (phenytoin sodium) by the UK Competition and …
Pfizer and Flynn rapped for overcharging on anti-epilepsy drug
August 6, 2015Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing
Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
